Thursday, October 9, 2025

Latest

Oncology Firm Erasca Eyes US$300 Million IPO

Precision oncology company Erasca Inc. (NASDAQ: ERAS) began trading on the Nasdaq Global Select Market today under the symbol “ERAS”. The firm’s initial public offering is looking to raise US$300.0 million and is expected to close on July 20, 2021.

The offering will be conducted through the issuance of 18,750,000 common shares selling at US$16.00 per share.

The company granted a 30-day over-allotment option to purchase additional 2,812,500 common shares at the same IPO price, potentially bringing proceeds up to US$345.0 million. J.P. Morgan, Morgan Stanley, BofA Securities, Evercore ISI, and Guggenheim Securities are all acting as joint bookrunners for the said offering.

According to its profile, Erasca is a clinical-stage precision oncology company focused on therapy solutions for RAS/MAPK pathway-driven cancers. The company got its name from its mission statement to “erase cancer”.


Information for this briefing was found via Sedar and Erasca. The author has no securities or affiliations related to this organization. Not a recommendation to buy or sell. Always do additional research and consult a professional before purchasing a security. The author holds no licenses.

Video Articles

Fortune Bay: The Potential Billion Dollar Project

Japan Gold Enters New Chapter as Barrick Alliance Concludes – John Proust

Barrick Mining’s “Company Defining [Gold] Discovery”

Recommended

Nord Precious Metals Produces High Grade Silver Concentrate From Tailings

ESGold Secures $9 Million In Non-Dilutive Funding From Ocean Partners

Related News

SPAC Acropolis Infrastructure Aims To Conduct A US$300 Million IPO

Blank check company Acropolis Infrastructure Acquisition Corp. is looking to raise US$300 million for its...

Friday, July 9, 2021, 10:57:00 AM

Medical Cannabis Firm Akanda Prices US$16 Million IPO

International medical cannabis firm Akanda Corp. (Nasdaq: AKAN) goes public today on the Nasdaq Capital...

Tuesday, March 15, 2022, 02:26:00 PM

Mining Firm Austin Gold Prices US$13 Million IPO

Gold exploration company Austin Gold Corp. (NYSE: AUST) began trading on the New York Stock...

Wednesday, May 4, 2022, 02:20:00 PM

Biopharmaceutical Firm Candel Therapeutics Prices Downsized US$72 Million IPO

Late clinical stage biopharmaceutical company Candel Therapeutics Inc. (Nasdaq: CADL) started publicly trading on the...

Tuesday, July 27, 2021, 10:47:00 AM

Biotech SPAC Larkspur Health Acquisition Prices US$75 Million IPO

After filing for registration in May 2021, special purpose acquisition company Larkspur Health Acquisition Corp....

Tuesday, December 21, 2021, 01:54:00 PM